Cellemedy
Latest round
- Seed
Last raised
- Dec 2020
Total raised
- $3.7M
Investors
- 3
About Cellemedy
Based in Gyeonggi-do, South Korea, and founded in 2016, Cellemedy Inc.Founded in Seongnam, South Korea, Cellemedy Inc. focuses on the development of innovative therapeutic proteins. The company has maintained a consistent strategy without significant pivots. Details about the founder's prior ventures are not available.Cellemedy Inc. specializes in the development of next-generation therapeutic proteins aimed at transforming conventional antibody treatments., is designed to target multiple pathways in oncology, enhancing the efficacy of immunotherapy treatments. The company’s drug conjugate pipeline focuses on providing advanced solutions for cancer care, with a commitment to replacing existing therapies with more effective alternatives. These products are intended for use primarily in the oncology sector, addressing significant unmet needs in cancer treatment.Cellemedy operates on a business model that involves partnerships and collaborations with pharmaceutical firms and healthcare institutions, facilitating the distribution of its therapeutic proteins. Revenue generation stems from licensing agreements, research collaborations, and direct sales of their proprietary products such as those under the T-sphaera?? platform. Given the nature of biotechnology, transactions are structured to support long-term partnerships, where clients may engage in joint ventures or clinical trials to validate the efficacy of Cellemedy’s offerings. The company is positioned to capitalize on the growing need for advanced cancer therapies, with specific pricing plans for their products reflecting the premium nature of biopharmaceutical innovations.
Who invested in Cellemedy
3 investors across 1 round
See all investors in Cellemedy
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Dec 1, 2020
Amount
$3.7M
Investors
Questions about Cellemedy
Who invested in Cellemedy?
Cellemedy has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Cellemedy raised?
Cellemedy has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Cellemedy last raise money?
Cellemedy's most recent round on record is a Seed, in Dec 2020.
What does Cellemedy do?
Based in Gyeonggi-do, South Korea, and founded in 2016, Cellemedy Inc.
Where is Cellemedy headquartered?
Cellemedy is headquartered in Seongnam-si, South Korea.
Which VCs invest in companies like Cellemedy?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back pharmaceuticals companies at Cellemedy's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Seed
Raising like Cellemedy? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.